Respiratory, Autonomic, Hematology & Oncology Pharmacology

Asthma/COPD inhalers & biologics, autonomic agonists/antagonists, anticoagulants, antiplatelets, thrombolytics, immunosuppressants, and classic/targeted antineoplastics.

Category
Top 200 Prescribed Drugs (Brand, Generic, Class & MOA)
Level
advanced
Languages
en → en
Cards
32
Markdown
Respiratory, Autonomic, Hematology & Oncology Pharmacology (.md)

Flashcards (32)

#Front (Term / Question)Back (Definition / Answer)ExampleMultiple-Choice Options
1Omalizumab, Mepolizumab/Benralizumab & Dupilumab — Severe Eosinophilic/Allergic Asthma BiologicsOmalizumab: anti-IgE mAb (binds Fc region of free IgE). Mepolizumab: anti-IL-5 mAb; Benralizumab: anti-IL-5Ralpha mAb (depletes eosinophils). Dupilumab: anti-IL-4Ralpha mAb blocking both IL-4 and IL-13 signaling (treats severe eosinophilic asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps).
2Unfractionated Heparin (UFH) vs Enoxaparin (LMWH) vs Fondaparinux — Mechanism, Monitoring & Renal ClearanceActivate antithrombin III: UFH catalyzes inactivation of both Factor IIa (thrombin) and Factor Xa (monitored via aPTT; safe in ESRD; completely reversed by protamine sulfate). Enoxaparin (LMWH) and Fondaparinux (synthetic pentasaccharide) preferentially inhibit Factor Xa (monitored via anti-Xa levels if needed; renally cleared—avoid or dose-reduce if CrCl < 30 mL/min).
3Tacrolimus & Cyclosporine vs Mycophenolate Mofetil vs Sirolimus — Transplant ImmunosuppressantsTacrolimus (binds FKBP-12) and cyclosporine (binds cyclophilin) inhibit calcineurin -> prevent NFAT dephosphorylation and IL-2 transcription (both cause dose-limiting nephrotoxicity, hypertension, and neurotoxicity; tacrolimus causes post-transplant diabetes, cyclosporine causes gingival hyperplasia and hirsutism). Mycophenolate inhibits IMP dehydrogenase (blocks de novo purine synthesis in T/B cells; GI toxicity/cytopenias). Sirolimus binds FKBP-12 to inhibit mTOR (blocks IL-2 receptor signaling; non-nephrotoxic).
4Filgrastim (G-CSF), Epoetin Alfa (EPO) & Romiplostim/Eltrombopag — Hematopoietic Growth FactorsFilgrastim/pegfilgrastim stimulate granulocyte proliferation to prevent febrile neutropenia (causes bone pain). Epoetin alfa/darbepoetin stimulate erythropoiesis in anemia of CKD (causes hypertension and thrombosis if Hb > 11 g/dL). Romiplostim and eltrombopag are thrombopoietin (TPO) receptor agonists used in refractory immune thrombocytopenia (ITP).
5Apixaban & Rivaroxaban vs Dabigatran — DOAC Mechanisms & Specific Reversal AgentsApixaban and rivaroxaban directly inhibit free and clot-bound Factor Xa (reversed by andexanet alfa or 4-factor PCC). Dabigatran is a direct oral thrombin (Factor IIa) inhibitor (reversed specifically by the monoclonal antibody fragment idarucizumab / Praxbind).
6Rasburicase vs Allopurinol — Prevention and Management of Tumor Lysis Syndrome (TLS)Aggressive lysis of high-turnover hematologic malignancies releases massive intracellular K+, PO4-, and nucleic acids (hyperuricemia, hypocalcemia, acute urate nephropathy). Allopurinol prevents NEW uric acid formation by inhibiting xanthine oxidase; Rasburicase is recombinant urate oxidase that directly oxidizes EXISTING uric acid into water-soluble allantoin (contraindicated in G6PD deficiency due to H2O2 production).
7Ipratropium (SAMA) & Tiotropium/Umeclidinium (LAMA) — Mechanism & Role in COPD vs AsthmaCompetitively block M3 muscarinic receptors on airway smooth muscle, preventing vagally mediated bronchoconstriction and mucus secretion. LAMAs are cornerstone maintenance therapy in COPD and severe asthma. Adverse effects: Dry mouth and acute urinary retention in men with BPH.
85-Fluorouracil (5-FU) / Capecitabine & Cytarabine — Pyrimidine Antimetabolites5-FU (and oral prodrug capecitabine) forms 5-FdUMP, which complexes with leucovorin to inhibit thymidylate synthase, causing 'thymine-less death' in GI/breast cancers (causes myelosuppression and palmar-plantar erythrodysesthesia / hand-foot syndrome). Cytarabine (Ara-C) inhibits DNA polymerase in AML (causes pancytopenia and cerebellar ataxia).
9Alteplase (tPA) & Tenecteplase (TNK) vs Tranexamic Acid (TXA) — Fibrinolytics vs AntifibrinolyticAlteplase and tenecteplase convert plasminogen to plasmin to lyse fibrin clots in acute ischemic stroke (<4.5h), massive PE, and STEMI (contraindicated in prior hemorrhagic stroke, recent brain/spinal surgery, or active bleeding). Tranexamic acid is a synthetic lysine analog that blocks plasminogen conversion to plasmin, used in trauma hemorrhage (CRASH-2), postpartum hemorrhage, and menorrhagia.
10Cyclophosphamide & Ifosfamide — Alkylating Mechanism, Hemorrhagic Cystitis & Mesna ProphylaxisNitrogen mustards activated by hepatic CYP450 to cross-link DNA at guanine N-7 positions. Hepatic metabolism produces acrolein, a urotoxic metabolite that causes hemorrhagic cystitis and bladder transitional cell carcinoma—prevented by rigorous IV hydration and Mesna (which binds and neutralizes acrolein in the bladder).
11Montelukast — Leukotriene Receptor Antagonist Mechanism, Niche Indications & FDA Boxed WarningBlocks CysLT1 receptors, preventing bronchoconstriction and edema caused by leukotrienes LTC4, LTD4, and LTE4. Particularly effective in aspirin-exacerbated respiratory disease (Samter triad) and exercise-induced bronchospasm. Carries an FDA Boxed Warning for serious neuropsychiatric events (agitation, depression, vivid nightmares, suicidality).
12Pembrolizumab, Nivolumab & Ipilimumab — Immune Checkpoint Inhibitors & Immune-Related Adverse Events (irAEs)Pembrolizumab/nivolumab block PD-1 on T cells; atezolizumab blocks PD-L1 on tumor cells; ipilimumab blocks CTLA-4 on T cells. Release the brakes on cytotoxic T-cell antitumor immunity. Cause autoimmune inflammatory toxicities (colitis, pneumonitis, thyroiditis, hypophysitis, hepatitis, myocarditis), managed by holding drug and administering systemic corticosteroids.
13Tamoxifen vs Anastrozole/Letrozole — Endocrine Therapy Selection in ER-Positive Breast CancerTamoxifen (SERM) is effective in both premenopausal and postmenopausal women (requires CYP2D6 conversion to active endoxifen; avoid strong CYP2D6 inhibitors like fluoxetine/paroxetine). Aromatase inhibitors (anastrozole, letrozole, exemestane) block peripheral conversion of androgens to estrogens and are first-line in postmenopausal women (cause arthralgias and osteoporosis).
14Bethanechol & Pilocarpine vs Neostigmine & Pyridostigmine — Cholinergic Agonist Clinical ApplicationsBethanechol (direct M3 agonist for postoperative/neurogenic urinary retention) and Pilocarpine (direct muscarinic agonist for acute glaucoma and Sjögren syndrome xerostomia). Neostigmine (reversible AChE inhibitor for postoperative ileus/Ogilvie syndrome and neuromuscular blockade reversal) and Pyridostigmine (oral AChE inhibitor first-line for Myasthenia Gravis; does not cross BBB).
15Tiotropium + Olodaterol + Fluticasone — GOLD COPD Escalation Principle (ABE Groups)According to GOLD guidelines, symptomatic COPD (Group B) and frequent exacerbators (Group E) are initiated on dual bronchodilator therapy (LABA + LAMA). Triple therapy (LABA + LAMA + ICS) is reserved for patients with recurrent exacerbations and blood eosinophils >= 300 cells/uL (or concomitant asthma).
16Tamsulosin & Finasteride Combination in Benign Prostatic Hyperplasia — Dynamic vs Static ObstructionTamsulosin (selective alpha-1A antagonist) rapidly relaxes prostatic and bladder neck smooth muscle within days (relieves the dynamic component of BPH obstruction). Finasteride (5-alpha-reductase inhibitor) shrinks the hyperplastic glandular epithelium over 6–12 months (relieves the static component, reduces hematuria and acute urinary retention).
17Epinephrine Auto-Injector (EpiPen) — Exact Dose, Route, Anatomic Site & Mechanism in AnaphylaxisIntramuscular (IM) injection into the mid-anterolateral thigh (vastus lateralis): 0.3–0.5 mg of 1 mg/mL (1:1,000) solution in adults (0.3 mg via standard adult auto-injector; 0.15 mg in children 15–30 kg). Alpha-1 vasoconstriction reverses hypotension and laryngeal mucosal edema; beta-2 agonism relieves bronchospasm and stabilizes mast cells.
18Adalimumab, Infliximab & Etanercept — TNF-Alpha Inhibitors & Mandatory Pre-Treatment ScreeningInfliximab and adalimumab are monoclonal antibodies against TNF-alpha; etanercept is a decoy TNF receptor-IgG Fc fusion protein (note: infliximab/adalimumab treat Crohn disease and sarcoidosis, whereas etanercept does not). Because TNF-alpha maintains caseating granulomas, all require screening for latent Tuberculosis (IGRA/PPD) and Hepatitis B prior to initiation.
19Cisplatin, Carboplatin & Oxaliplatin — Platinum Cross-Linking Agents & Signature ToxicitiesCross-link DNA strands to trigger apoptosis. Cisplatin causes severe nephrotoxicity (Fanconi syndrome/ATN; prevented by IV saline diuresis and amifostine) and ototoxicity. Carboplatin causes dose-limiting myelosuppression. Oxaliplatin causes cold-triggered acute dysesthesias and peripheral neuropathy.
20Phentolamine & Phenoxybenzamine — Alpha-Adrenergic Blockers in Pheochromocytoma & Beta-Blocker RulePhenoxybenzamine is an irreversible non-selective alpha-1/alpha-2 blocker used preoperatively for 10–14 days before pheochromocytoma resection; phentolamine is a reversible non-selective alpha blocker used for intraoperative hypertensive crises or extravasation of norepinephrine. Alpha blockade MUST be established BEFORE giving any beta-blocker to prevent unopposed alpha-1 vasoconstriction and fatal hypertensive crisis.
21Fluticasone & Budesonide — Inhaled Corticosteroid (ICS) Mechanism & Local Prevention CounselingInhibit phospholipase A2 and NF-kB transcription of inflammatory cytokines, suppressing eosinophilic airway inflammation and upregulating beta-2 receptors. Patients must rinse their mouth and spit ('rinse and spit') after every use to prevent oropharyngeal candidiasis (thrush) and dysphonia.
22Clopidogrel, Prasugrel & Ticagrelor — P2Y12 Platelet Inhibitor ComparisonBlock ADP-mediated platelet aggregation (preventing GPIIb/IIIa activation). Clopidogrel and prasugrel are thienopyridine prodrugs that irreversibly block P2Y12 (clopidogrel requires CYP2C19 activation; prasugrel is contraindicated in prior stroke/TIA). Ticagrelor is a direct, reversible P2Y12 inhibitor that does not require hepatic activation (causes benign dyspnea via adenosine reuptake inhibition).
23Warfarin (Coumadin) — Mechanism, Initial Prothrombotic Window, INR Targets & Reversal ProtocolInhibits vitamin K epoxide reductase (VKORC1), preventing gamma-carboxylation of Factors II, VII, IX, X, and Proteins C and S. Because Protein C and Factor VII have the shortest half-lives (~6–8h), warfarin causes a transient hypercoagulable state and skin necrosis (esp. in Protein C deficiency) unless bridged with heparin. Target INR 2.0–3.0 (2.5–3.5 for mechanical mitral valves). Reversed rapidly with 4-factor PCC + IV Vitamin K.
24Imatinib (Gleevec), Trastuzumab (Herceptin) & Rituximab (Rituxan) — Targeted Oncology ClassicsImatinib inhibits the BCR-ABL tyrosine kinase (Philadelphia chromosome t(9;22) in CML) and c-KIT in GIST (causes fluid retention/periorbital edema). Trastuzumab is a mAb against HER2/neu (ErbB2) in breast/gastric cancer (causes reversible cardiotoxicity; check baseline ECHO). Rituximab is a chimeric anti-CD20 mAb used in B-cell non-Hodgkin lymphomas, CLL, RA, and GPA (risk of HBV reactivation and PML).
25Doxorubicin (Adriamycin) vs Bleomycin — Anthracycline vs Glycopeptide Antitumor AntibioticsDoxorubicin intercalates DNA, inhibits topoisomerase II, and generates iron-mediated free radicals; causes cumulative dose-dependent dilated cardiomyopathy (prevented by iron chelator dexrazoxane). Bleomycin generates free radicals that induce DNA strand breaks (used in Hodgkin lymphoma ABVD and testicular cancer); causes dose-limiting pulmonary fibrosis and flagellate hyperpigmentation (minimal myelosuppression).
26Methotrexate — Mechanism in Malignancy vs Autoimmune Disease, Leucovorin Rescue & Organ ToxicitiesFolic acid analog that competitively inhibits dihydrofolate reductase (DHFR) (and increases anti-inflammatory adenosine in RA/psoriasis). High-dose oncology regimens require leucovorin (folinic acid) rescue to protect normal bone marrow and GI mucosa. Toxicities: Hepatotoxicity/hepatic fibrosis, pulmonary fibrosis, myelosuppression, mucositis, and severe teratogenicity.
27Norepinephrine vs Epinephrine vs Phenylephrine vs Dobutamine — Vasopressor & Inotrope Receptor ProfilesNorepinephrine (alpha-1 > beta-1; first-line vasopressor in septic/cardiogenic shock). Epinephrine (beta-1 = beta-2 > alpha-1 at low dose, alpha-1 dominant at high dose; first-line in anaphylaxis and cardiac arrest). Phenylephrine (pure alpha-1 agonist; causes reflex bradycardia). Dobutamine (beta-1 > beta-2 agonist; inodilator that increases cardiac output and decreases SVR).
28Albuterol (SABA) vs Salmeterol/Formoterol (LABA) — Beta-2 Agonist Mechanism & GINA Asthma Monotherapy RuleStimulate beta-2 adrenergic receptors (Gs -> adenylyl cyclase -> increased cAMP -> bronchial smooth muscle relaxation) and drive K+ into cells (causing hypokalemia and tremor). LABAs must NEVER be used as monotherapy in asthma without an inhaled corticosteroid (ICS) due to increased asthma-related mortality; GINA guidelines recommend ICS-formoterol as preferred reliever.
29Atropine, Glycopyrrolate & Benztropine — Antimuscarinic Clinical DifferencesAtropine crosses the BBB (treats symptomatic bradycardia and organophosphate poisoning). Glycopyrrolate is a quaternary amine that does NOT cross the BBB (used parenterally with neostigmine to block peripheral muscarinic bradycardia/salivation during paralytic reversal). Benztropine crosses the BBB to treat drug-induced parkinsonism and acute dystonia.
30Heparin-Induced Thrombocytopenia (HIT) — Pathophysiology, Timing, Paradoxical Thrombosis & TreatmentIgG antibodies form against PF4-heparin complexes (typically 5–10 days after heparin exposure), activating platelets via FcgammaRIIA receptors -> >50% platelet drop PLUS life-threatening arterial/venous thrombosis and skin necrosis. Immediately stop all heparin (and avoid warfarin initially) and start a direct thrombin inhibitor (argatroban in hepatic/renal failure or bivalirudin) or fondaparinux.
31Vincristine & Vinblastine vs Paclitaxel & Docetaxel — Microtubule Chemotherapy ComparisonVinca alkaloids inhibit beta-tubulin polymerization (prevent mitotic spindle assembly in M phase): Vincristine causes dose-limiting peripheral and autonomic neuropathy (paralytic ileus/foot drop), while Vinblastine 'blasts' the bone marrow. Taxanes (paclitaxel, docetaxel) hyperstabilize polymerized microtubules ('tax the mitotic spindle'), preventing disassembly (cause neuropathy and hypersensitivity).
32Hydroxyurea — Mechanism of Action & Clinical Benefit in Sickle Cell DiseaseInhibits ribonucleotide reductase (G1/S phase arrest in myeloproliferative neoplasms) and increases fetal hemoglobin (HbF, alpha2gamma2) levels in sickle cell disease. HbF prevents polymerization of deoxygenated HbS, reducing vaso-occlusive painful crises and acute chest syndrome.